Which CDMO Is Best For You? -- A Debate on Selection, Service, Talent and Technology

At times it’s too few choices, others too many when drug/therapy sponsors need to outsource to CDMOs. How do you know which is best for you, and your specific programs? What are the technologies and skill sets most valuable to sponsors of the different modalities – small molecule, biologics, cell and gene? What qualities should you look for in the CDMO team members you’ll be working with? Should sponsors select an end-to-end (full service) CDMO?

In June 2023, Outsourced Pharma Live brought together a panel of experts to offer their advice and best practices. Available on-demand thanks to the support of Ajinomoto Bio-Pharma Services.